Cargando…

Worldwide legislative challenges related to psychoactive drugs

ABSTRACT: The discovery of a “new” psychoactive substance is a relatively exceptional event, while the regulatory response usually involved the assessment of risks to public health and inclusion of the novel substance in the national list of controlled substances. However, in recent years we have wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Negrei, Carolina, Galateanu, Bianca, Stan, Miriana, Balalau, Cristian, Dumitru, Mircea Lucian Bogdan, Ozcagli, Eren, Fenga, Concettina, Kovatsi, Leda, Fragou, Domniki, Tsatsakis, Aristidis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455135/
https://www.ncbi.nlm.nih.gov/pubmed/28578694
http://dx.doi.org/10.1186/s40199-017-0180-2
_version_ 1783240990188896256
author Negrei, Carolina
Galateanu, Bianca
Stan, Miriana
Balalau, Cristian
Dumitru, Mircea Lucian Bogdan
Ozcagli, Eren
Fenga, Concettina
Kovatsi, Leda
Fragou, Domniki
Tsatsakis, Aristidis
author_facet Negrei, Carolina
Galateanu, Bianca
Stan, Miriana
Balalau, Cristian
Dumitru, Mircea Lucian Bogdan
Ozcagli, Eren
Fenga, Concettina
Kovatsi, Leda
Fragou, Domniki
Tsatsakis, Aristidis
author_sort Negrei, Carolina
collection PubMed
description ABSTRACT: The discovery of a “new” psychoactive substance is a relatively exceptional event, while the regulatory response usually involved the assessment of risks to public health and inclusion of the novel substance in the national list of controlled substances. However, in recent years we have witnessed the rapid emergence of new chemical substances, which elude international control and pose a challenge to existing processes and a threat to the credibility of control systems. We currently review and present characteristics of these legal and illegal new substances and issues regarding their global monitoring and regulatory measures already taken, or in the process of being taken, for their control. The concept of prohibition applied in active substance-related legislation is rather hazard ridden as balance is required between the ban on substances of potential therapeutic use and the access on the market of high-risk substances. GRAPHICAL ABSTRACT: Current and future laws regarding psychoactive compounds. [Image: see text]
format Online
Article
Text
id pubmed-5455135
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54551352017-06-06 Worldwide legislative challenges related to psychoactive drugs Negrei, Carolina Galateanu, Bianca Stan, Miriana Balalau, Cristian Dumitru, Mircea Lucian Bogdan Ozcagli, Eren Fenga, Concettina Kovatsi, Leda Fragou, Domniki Tsatsakis, Aristidis Daru Review Article ABSTRACT: The discovery of a “new” psychoactive substance is a relatively exceptional event, while the regulatory response usually involved the assessment of risks to public health and inclusion of the novel substance in the national list of controlled substances. However, in recent years we have witnessed the rapid emergence of new chemical substances, which elude international control and pose a challenge to existing processes and a threat to the credibility of control systems. We currently review and present characteristics of these legal and illegal new substances and issues regarding their global monitoring and regulatory measures already taken, or in the process of being taken, for their control. The concept of prohibition applied in active substance-related legislation is rather hazard ridden as balance is required between the ban on substances of potential therapeutic use and the access on the market of high-risk substances. GRAPHICAL ABSTRACT: Current and future laws regarding psychoactive compounds. [Image: see text] BioMed Central 2017-06-02 /pmc/articles/PMC5455135/ /pubmed/28578694 http://dx.doi.org/10.1186/s40199-017-0180-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review Article
Negrei, Carolina
Galateanu, Bianca
Stan, Miriana
Balalau, Cristian
Dumitru, Mircea Lucian Bogdan
Ozcagli, Eren
Fenga, Concettina
Kovatsi, Leda
Fragou, Domniki
Tsatsakis, Aristidis
Worldwide legislative challenges related to psychoactive drugs
title Worldwide legislative challenges related to psychoactive drugs
title_full Worldwide legislative challenges related to psychoactive drugs
title_fullStr Worldwide legislative challenges related to psychoactive drugs
title_full_unstemmed Worldwide legislative challenges related to psychoactive drugs
title_short Worldwide legislative challenges related to psychoactive drugs
title_sort worldwide legislative challenges related to psychoactive drugs
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455135/
https://www.ncbi.nlm.nih.gov/pubmed/28578694
http://dx.doi.org/10.1186/s40199-017-0180-2
work_keys_str_mv AT negreicarolina worldwidelegislativechallengesrelatedtopsychoactivedrugs
AT galateanubianca worldwidelegislativechallengesrelatedtopsychoactivedrugs
AT stanmiriana worldwidelegislativechallengesrelatedtopsychoactivedrugs
AT balalaucristian worldwidelegislativechallengesrelatedtopsychoactivedrugs
AT dumitrumircealucianbogdan worldwidelegislativechallengesrelatedtopsychoactivedrugs
AT ozcaglieren worldwidelegislativechallengesrelatedtopsychoactivedrugs
AT fengaconcettina worldwidelegislativechallengesrelatedtopsychoactivedrugs
AT kovatsileda worldwidelegislativechallengesrelatedtopsychoactivedrugs
AT fragoudomniki worldwidelegislativechallengesrelatedtopsychoactivedrugs
AT tsatsakisaristidis worldwidelegislativechallengesrelatedtopsychoactivedrugs